Spine Metastases
19
11
12
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
5.3%
1 terminated out of 19 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (19)
Effectiveness Of Radiofrequency Ablation And Stabilization In Metastatic Spine Lesions By Positron Emission Computed Tomography (PET-CT) Confirmation
Single- vs. Two-Fraction Spine Stereotactic Radiosurgery for the Treatment of Vertebral Metastases
Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease
Spine Oncology Registry
Radiofrequency Ablation/Bone Augmentation + Radiotherapy vs Radiotherapy Alone
Dose-Escalated Spine SbRT for Localized Metastasis to the Spinal Column
Stereotactic Magnetic Resonance Guided Radiation Therapy
Studying a New Piece of Equipment That Can Help Plan Radiation Therapy of the Spine
Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases
Erector Spinae Plane Block in Spine Surgeries for Postoperative Pain
Definitive Radiation for High-Risk Spine Metastases
Radiation Therapy Alone Versus Radiation Therapy Plus Radiofrequency Ablation (RFA)/Vertebral Augmentation
Increased Early Pain Relief by Adding Vertebroplasty to SBRT
Post Operative RT for Limited Spine Metastases
Posterior Corpectomy in Thoracolumbar Spinal Metastatsis
Ablation and Cementoplasty for Painful Bone Lesions
Stereotactic Radiotherapy and Image-guided Intensity Modulated Radiotherapy for Spinal Metastatic Tumors
Minimally Invasive Surgery (MIS) for Spine Metastases
Health Economics Evaluation of Percutaneous Vertebroplasty Compared to Radiation Therapy in Patients With Painful Spine Metastases.